News

Creatd Earlier Announces Release Of iOS App For Its Flagship Product, Vocal

Creatd launches its first iOS app exclusively for its Vocal+ premium members to exponentially grow their audience on Vocal The app will launch to the general public on August 15th, 2022 The Vocal iOS app

byBenzinga Newsdesk

July 21, 2022

1 minute read

Creatd launches its first iOS app exclusively for its Vocal+ premium members to exponentially grow their audience on Vocal
The app will launch to the general public on August 15th, 2022
- The Vocal iOS app roadmap includes a new payment system and the tokenization of an in-app currency; Vocal Coins

Jefferies Downgrades IVERIC bio to Hold, Lowers Price Target to $20

By Benzinga Newsdesk

Today, 6:29 AM

Jefferies analyst Chris Howerton downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Hold and lowers the price target from $30 to $20.

ISEE

Trane Technologies Clocks 6% Revenue Growth In Q3, Misses Consensus; Reaffirms FY21 Outlook

By Anusuya Lahiri

Today, 6:29 AM

Trane Technologies PLC (NYSE:TT) reported third-quarter revenue growth of 6% year-over-year to $3.72 billion, missing the consensus of $3.78 billion. Organic…

FDA
News

Applied Therapeutics to Hold on Submitting a New Drug Application for its AT-007 for Treatment of Galactosemia Pending Additional Discussions with the FDA

By Luke J Jacobi

Today, 6:29 AM

The ongoing ACTION-Galactosemia Kids Phase 3 study is evaluating the impact of AT-007 treatment vs. placebo on clinical outcomes over time, including cognition, speech, behavior and motor skills. Clinical outcomes are

APLT

News

Velodyne Lidar Reports Autonomous Car Racing Series, ROBORACE, Selected Co. As Official Lidar Sensor Provider For Vehicles, No Terms Disclosed

By Benzinga Newsdesk

Today, 6:29 AM

Velodyne Official Lidar System Provider in Next Generation ROBORACE Vehicles SAN JOSE, Calif.--(BUSINESS WIRE)-- Velodyne Lidar, Inc. (NASDAQ:VLDR, VLDRW)) today announced ROBORACE, the world’s first autonomous

VLDR

Creatd Earlier Announces Release Of iOS App For Its Flagship Product, Vocal

Related Posts

Jefferies Downgrades IVERIC bio to Hold, Lowers Price Target to $20

Trane Technologies Clocks 6% Revenue Growth In Q3, Misses Consensus; Reaffirms FY21 Outlook

Applied Therapeutics to Hold on Submitting a New Drug Application for its AT-007 for Treatment of Galactosemia Pending Additional Discussions with the FDA

Velodyne Lidar Reports Autonomous Car Racing Series, ROBORACE, Selected Co. As Official Lidar Sensor Provider For Vehicles, No Terms Disclosed